Fig. 3: Waterfall plots of change in hs-CRP.
Waterfall plots of hs-CRP percentage changes from baseline to 12 weeks of individual participants in placebo (a) and the three clazakizumab dose groups (mITT analysis) 2.5 mg (b), 5 (c), 10 mg (d).
Fig. 3: Waterfall plots of change in hs-CRP. | Nature Medicine
